Stay updated on Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check25 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding notice was removed. This update does not affect the study details or data presented on the page.SummaryDifference0.4%

- Check61 days agoChange DetectedA site-wide notice about a government funding lapse and NIH Clinical Center status was added, with links to cc.nih.gov and opm.gov, and the revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedShow glossary was added to the page. The page now displays 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' entries were removed.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. This appears to be a minor, site-wide update that does not modify study content or data.SummaryDifference0.1%

Stay in the know with updates to Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.